Zoetis Inc. (ZTS)
| Market Cap | 76.93B |
| Revenue (ttm) | 6.54B |
| Net Income (ttm) | 1.66B |
| Shares Out | 475.50M |
| EPS (ttm) | 3.47 |
| PE Ratio | 46.42 |
| Forward PE | 37.17 |
| Dividend | $1.00 |
| Dividend Yield | 0.62% |
| Trading Day | January 26 |
| Last Price | $161.07 |
| Previous Close | $161.34 |
| Change ($) | -0.27 |
| Change (%) | -0.17% |
| Day's Open | 161.35 |
| Day's Range | 158.56 - 161.64 |
| Day's Volume | 966,369 |
| 52-Week Range | 92.27 - 174.35 |
These are some of the top stocks to buy if you want to make a play on the growth and strength of the Chinese economy. The post 9 Hot Stocks to Buy Now to Profit off Chinese Markets appeared fi...
Welcome to Alpha Trader. We have a special double bill today in honor of wildcard weekend coming up on the show. Eddy Elfenbein of Crossing Wall Street giving us his top five new stocks for 20...
Both stocks have at least five fiscal years of dividend growth history and come from the U.S. Dividend Champions List. An average and median increase of 15.13%.
Families are adopting, spending more on pets amid pandemic: Zoetis CEO
Shelters have seen pet adoptions increase 15% year over year. As Americans spend more time at home with their companions, it has led to more spending on pet care, animal pharmaceuticals provid...
Homebound families are spending more time and money on pets, Zoetis CEO Kristin Peck told CNBC's Jim Cramer on Wednesday.
Rising pet ownership rates and a steadily increasing average household spending provide a powerful tailwind to this investment theme. Pet food, animal health, veterinary equipment, and special...
The 2021 Market Outlook And Some New Stock Picks - Ryan Detrick And Eddy Elfenbein Join Alpha Trader
This week's Alpha Trader podcast features hosts Aaron Task and Stephen Alpher speaking with LPL Financial's Ryan Detrick and Eddy Elfenbein, editor of the Crossing Wall Street blog and portfol...
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis will report Q4 and full year 2020 financial results on Tuesday, Feb 16, 2021.
Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks. The post 8 Pet Stocks That Will Make You Purr appeared first on...
These biotech stocks allow you to profit off the innovations that are giving us longer, healthier lives through the companies that make them. The post 5 Rational Biotech Stocks to Buy appeared...
True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #JPM2021--Zoetis to present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021.
ZTS is the leader in the animal healthcare space, providing a multitude of products/services to customers. The company continues to have impressive earnings, even during the COVID pandemic and...
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis declares Q1'21 dividend: Board approves 25% increase.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis appoints Antoinette (Tonie) Leatherberry to its Board of Directors.
Zoetis (ZTS) reported earnings 30 days ago. What's next for the stock?
More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #DiversityandInclusion--For the third year in a row, Zoetis has been named one of the "Top 75 Companies for Executive Women" by Working Mother Media.
Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #ESG--Zoetis is the first animal health company to issue Environmental, Social and Governance (ESG) Review based on leading sustainability frameworks.
Zoetis (ZTS) gets marketing authorization for Librela, for monthly alleviation of osteoarthritis pain in dogs.
ZAVENTEM, Belgium--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis has received European Commission Marketing Authorization for Librela (bedinvetmab) for alleviation of osteoarthritis (OA) pain...
Zoetis Inc.'s (ZTS) CEO Kristin Peck on Q3 2020 Results - Earnings Call Transcript
Pet adoption demand drives strong Q3 earnings for Zoetis
Zoetis, the largest global animal health company, reported third quarter earnings results. The CEO of Zoetis Kristin Peck, says she sees long-term trends where people tend more to their pets e...
Zoetis (ZTS) beats earnings and sales estimates in the third quarter. The company raises 2020 guidance.
Zoetis (ZTS) saw a big move last session, as its shares jumped nearly 7% on the day, amid huge volumes.
Zoetis (ZTS) delivered earnings and revenue surprises of 23.60% and 10.90%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Zoetis earnings beat views and the animal health giant hiked its guidance. Zoetis stock was little changed after spiking to a record high Wednesday.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis reports third quarter 2020 financial results.
Zoetis (ZTS) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Zoetis (ZTS) will provide updates on earnings, revenues and other pipeline developments when its releases third-quarter 2020 results.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis to participate in the Credit Suisse Virtual Healthcare Conference on Nov. 10.
Is (ZTS) Outperforming Other Medical Stocks This Year?
Zoetis (ZTS) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Nearby support on the charts suggests that the pharmaceuticals sector could be one to watch over the last few months of 2020.
Chewy, Zoetis and FreshPet are just a couple of the names on our list of pet stocks to buy. Let's look at this growing industry more closely.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #dividend--Zoetis declares fourth quarter 2020 dividend.
These four pet stocks should benefit from both increased ownership and higher spending as the "humanization" of pets continues. The post 4 Pet Stocks Catering to Stay-at-Home Trends appeared f...
We highlight the most attractive opportunities this month, by reviewing notable price moves and rating changes in our research.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis to report third quarter 2020 financial results on Nov. 5.
One of my friends and I were discussing the markets, and he drew my attention to a company that I was not familiar with: Covetrus (NASDAQ:CVET). The post The Pet Health Care Market Continues t...
Zoetis (NYSE:ZTS), a class-leading animal health and vaccine company, including animal-to-human virus vaccines, used to be a subsidiary of pharmaceutical giant Pfizer (NYSE:PFE), but it spun o...
A handful of pharmaceutical stocks have been on fire lately, but I'm writing for a "buy" prescription for five of the best names now.
Despite the economic challenges of the pandemic, Americans are spoiling their pets. Profit from that hot market with these top growth stocks.
Considering the higher cost debt can be refinanced at a much lower interest rate, I expect Zoetis to return to a share buyback program rather than paying down debt.
PARSIPPANY, N.J.--(BUSINESS WIRE)---- $ZTS #animalhealth--Zoetis will present at the 18th Annual Morgan Stanley Healthcare Conference on Wednesday, Sept.
About ZTS
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, which are biological preparations to prevent diseases of the respiratory, gastrointestinal, and reproductive tracts or induce a specific immune response; anti-infectives that prev... [Read more...]
| Industry Drug Manufacturers-Specialty & Generic | IPO Date Feb 1, 2013 |
| CEO Kristin Peck | Employees 10,600 |
| Stock Exchange NYSE | Ticker Symbol ZTS |
Financial Performance
In 2019, Zoetis's revenue was $6.26 billion, an increase of 7.47% compared to the previous year's $5.83 billion. Earnings were $1.50 billion, an increase of 5.04%.
Analyst Forecasts
According to 21 analysts, the average rating for Zoetis stock is "Buy." The 12-month stock price forecast is 185.00, which is an increase of 14.86% from the latest price.